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E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic
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Abstract: Pancreatic ductal adenocarcinoma (PDAC) pathology is known for its uncontrollable progress due to highly invasive
characteristics and refractory behavior against existing chemotherapies. The aberrant expression of CDH1 (expresses the protein
E-cadherin) is associated with increased overall survival in various cancers, however, E-cadherin expression in PDAC progression has
remained elusive. We investigated the impact of exogenously elevated E-cadherin levels on the tumorigenicity of transduced low grade
and metastatic PDAC cell lines, Panc-1 and AsPC-1, respectively. Constitutive expression of E-cadherin promoted a more hybrid E/M
state in AsPC-1 cells, while it was associated with the acquisition of a more epithelial-like state in Panc1 cells. Our study suggests that
E-cadherin may play differential roles in determining the metastatic characteristics of primary and metastatic pancreatic cancer cells.
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1. Introduction
In terms of availability of effective therapies, pancreatic
ductal adenocarcinoma (PDAC) remains a challenging
tumor both due to the intracorporeal location of the
pancreas and strong resistance that rapidly develops to
chemotherapy (Swayden et al., 2018). Most PDAC cases
are diagnosed at late stages where the tumor has already
metastasized and/or surgical intervention is no longer
possible (Moletta et al., 2019). Pancreatic cancer owes
its aggressive biology to its cancer stem cell (CSC)-like
characteristics, whereby pancreatic cancer cells display
abilities of self-renewal, efflux of drugs, and retention of
migration properties. Maintenance of CSCs is enabled in a
process called epithelial to mesenchymal transition (EMT),
in which cells undergo morphological changes from an
epithelial to a mesenchymal phenotype accompanied
by the concomitant induction in the expression of those
transcription factors related to EMT (Bhagwandin and
Shay, 2009).
EMT-promoting signaling pathways are associated
with malignant transformation. A clear-cut of losing all
epithelial characteristics while gaining mesenchymal
ones stays as theoretical because the cells remain more
like in an intermediate phenotypic spectrum (Zhang and

Weinberg, 2018). When cancer cells acquire mesenchymal
traits and simultaneously express epithelial features, this
interphase state is described as hybrid E/M (Kroger et al.,
2019). The CDH1 gene (which encodes the E-cadherin
protein and will be referred to as such in the remainder
of the manuscript) is the main gene that mediates the
epithelial characteristics via binding to the anchoring
catenin proteins. Through bridging E-cadherin with the
actin cytoskeleton, catenins contribute to E-cadherin’s
key role in conferring the adherent properties of the
epithelial cells. However, the function of E-cadherin in
cancer remains elusive due to the existence of opposing
results reported by different studies. As loss of cell-tocell adhesion and acquisition of mesenchymal markers is
associated with the migratory capacity of cells, E-cadherin
has been considered as a tumor suppressor gene for
years. Chao et al. suggested that E-cadherin reexpression
provides a survival advantage to the malignant cells and
exerts a protecting effect on micrometastases (Chao et
al., 2010) that lowers the cytotoxicity of chemotherapy in
prostate cancer. Interestingly, E-cadherin is expressed in
most carcinomas, including metastatic ones (Petrova et al.,
2016). Suppression of E-cadherin expression is associated
with a diminished rate of proliferation and viability (Song
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et al., 2019). Based on these facts, the role of E-cadherin
in cancer biogenesis needs to be described more precisely.
Hence, the goal of this study was to investigate the role
of E-cadherin expression in a primary and metastatic
pancreatic cancer cell line.
2. Material and methods
2.1. Cell cultures
The parental Panc-1 (ATCC®, USA) cell line was cultured
with Dulbecco’s Modified Eagle’s Medium, High Glucose
(GIBCO, USA); the parental AsPC-1 (ATCC®, USA) cell
line was cultured with RPMI 1640 Medium (GIBCO,
USA). Both media formulations were supplemented with
10% fetal bovine serum (FBS) (GIBCO, USA) and 1%
penicillin/streptomycin/amphotericin (PSA) (GIBCO,
USA). The media were changed every two days and the
cells were incubated in a humidified chamber at 37 °C in
5% CO2.
2.2. Viral particles and gene activation
Panc-1 and AsPC-1 cells were transduced with lentiviral
activation particles of CDH1 (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA) and control lentiviral
activation particles (Santa Cruz Biotechnology, Inc.) that
lack any protein-coding gene sequences as instructed by
the manufacturer (Ran et al., 2013). CDH1-activated cells
were named EPanc-1 and EAsPC-1 and control cells were
named cPanc-1 and cAsPC-1.
2.3. Immunocytochemistry analysis
E-cadherin-activated and control Panc-1 and AsPC-1 cells
were seeded on an 8-well chamber slide at a density of 104
cells/well. Briefly, the cells were washed with phosphatebuffered saline (PBS) and fixed with 4% paraformaldehyde
(P6148, Sigma-Aldrich Corp., St. Louis, MO, USA) for 20
min at room temperature. Cells were then washed with
PBS and permeabilized with 0.1% Triton-X 100 (X100,
Sigma-Aldrich Corp.) for 20 min at room temperature.
This procedure was followed by blocking with 10%
goat serum (GS, 31872, Thermo Fisher Scientific Inc.,
Waltham, MA, USA) for 1 h and conjugating E- cadherin,
vimentin, and Snail antibodies (Human EMT-3 Color
Immunocytochemistry Kit, Cat. No. SC026, R&D Systems,
Inc., Minneapolis, MN, USA) at room temperature for 3 h at
a concentration 1:50 in PBS. DAPI (5 µg/mL) was used for
nuclear staining and slides were viewed under a confocal
microscope. Images were taken at 20 × magnification.
2.4. Western blot analysis
Cellular pellets were collected and lysed using the radioimmunoprecipitation assay (RIPA) buffer (Sigma-Aldrich
Corp., USA) supplemented with protease and phosphatase
inhibitor cocktail and probed against primary antibodies
including E-cadherin, Snail, Slug, N-cadherin, Zeb-1,
vimentin, and β-catenin (antibodies included in EMT

sampler kit, Cell Signaling Technology, Inc., Danvers,
MA, USA); Nf-κB p65 (Cell Signaling Technology, Inc.);
phospho-Akt (Ser 473) (Cell Signaling Technology, USA);
Met, CD44, c-MYC (antibodies included in Wnt/β-catenin
activated targets sampler kit, Cell Signaling Technology,
Inc.); Klf4 (R&D Systems, Inc.); Nanog (R&D Systems,
Inc.), GAPDH (Cell Signaling Technology, Inc.).
2.5. Migration and invasion assay
CDH1-activated Panc-1 and AsPC-1 cells were seeded
onto 6-well plates at 90% confluence and the scratch
assay was performed according to the manufacturer’s
instructions (Liang et al., 2007). As for the invasion assay,
EAsPC-1 cells were trypsinized and cultured in invasion
Boyden chambers (Cell Biolabs, Inc., San Diego, CA, USA)
according to the manufacturer’s protocol (Quinn et al.,
2017).
2.6. Sphere formation assay
CDH1-transduced Panc-1 and AsPC-1 cells were cultured
in nonadherent cell culture plates and treated with sphere
formation media (SFM) consisting of 2% B27, 1% insulintransferin-selenium (ITS) (GIBCO, USA), 1% PSA, 20
ng/mL bFGF (GIBCO, USA), 20 ng/mL rhEGF (GIBCO,
USA), and 0.4% BSA (GIBCO, USA). Cells were incubated,
with replenishing SFM every 2 days, until spheres with a
diameter ranging from 40 µM (smallest) to 128 µM were
observed and evaluated.
2.7. Colony formation assay
CDH1-activated Panc-1 and AsPC-1 cells were seeded
onto 6-well plates at densities of 250, 500, and 1000 cells/
well. Cells were incubated for two weeks, stained with
0.5% crystal violet solution (Sigma-Aldrich Corp.), and
average colony numbers were calculated.
2.8. Statistical analysis
Statistical analysis was done with GraphPad Prism 5
(GraphPad Software, La Jolla, CA, USA) and comparisons
were made by using two-way analysis of variance (ANOVA)
and Bonferroni’s test as a posttest and unpaired t-test,
where applicable. The value of P < 0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Immunocytochemistry analysis
The levels of EMT proteins upon E-cadherin activation
were evaluated in both cell lines. According to this,
Snail (red signal, Figures 1a–1d), which is an important
repressor of E-cadherin, was upregulated in both cell lines
suggesting a hybrid state of EMT/MET.
3.1. Confirmation of E-cadherin activation and expression patterns of EMT
Figure 2a shows that the initial protein level of E-cadherin
is lower in Panc-1 cells when compared to the AsPC-1 cells.
The overexpression of E-cadherin and the fold changes for
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Figure 1. (a–d) Triple immunocytochemistry staining of EMT markers; Snail(red)/vimentin(green)/E-cadherin(white)
and cell nucleus stained with DAPI.

other EMT-related markers upon it are presented in Figure
2a. EMT markers, including ZEB-1 and β-catenin, were
upregulated in EPanc-1(Figure 2b) and downregulated in
EAsPC-1 (Figure 2c). A significant increase in N-cadherin
for EAsPC-1 cells was also recorded (Figure 2c).
3.2. Migration and invasion assay
The migration properties of EPanc-1 cells were analyzed
with the scratch assay (Figures 3a–3d). EPanc-1 cells closed
57% of the scratched area within 4 days, while cPanc-1 cells
migrated at a faster rate, closing the gap completely within
4 days (Figure 3e). Due to the inconvenience of AsPC-1
cells, which float freely in the cell culture environment
(Chen et al., 1982), we were unable to measure the possible
changes in migration using the scratch assay. Therefore,
only protein quantification data for the metastatic
marker, preMet/Met, was determined as a read-out for
alterations in migration (Figure 3f). Also, pre-Met levels
were upregulated in EAsPC-1 cells in contrast to those in
EPanc-1 cells (Figure 3f). According to this, pre-Met was
slightly (<1.5-fold) upregulated in EAsPC-1 cells (Figure
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3g), whereas it was downregulated in EPanc-1 cells (Figure
3h). Since it was not feasible to apply the scratch assay to the
poorly adherent AsPC-1 cells, the invasion and migration
assays were employed to evaluate their migratory capacity.
Based on our findings, the invasive potential of AsPC-1
cells remained the same as before the exogenous increase
in the E-cadherin expression (~1 fold) (Figure 3i), while
the migration of the EAsPC-1 cells was slightly increased
(<1.5-fold) compared to cAsPC-1 cells (Figure 3j).
3.3. Sphere and colony formation assay
In our study, the formation of colonies and spheres
(ranging between 40 to 140 µm in diameter) was 4
times less in EPanc-1 cells than in cPanc-1 cells (Figures
4a–4b). Both cAsPC-1 and EAsPC-1 cells were unable
to form colonies (data not shown); rather, the cAsPC-1
cells formed a botryoid (Figure 4b). On the other hand,
EAsPC-1 cells were able to form a regular spheroid form
within the given diameter range (Figure 4b). Increased
levels of the Krüppel-like factor (KLF4) (Figure 4c) were
measured in EPanc-1 cells, while a similar increase in
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Figure 2. (a) Representative western blot images for both cell lines. (b) Relative bar graphs for the changes in EMT and EMTrelated protein expressions in EPanc-1 and cPanc-1 cells. (c) Relative bar graphs for the changes in EMT and EMT-related
protein expressions in EAsPC-1 and cAsPC-1. Mean ± SD; *P < 0.05, **P < 0.01, and ***P < 0.001, vs. the control group.

EAsPC-1 cells was absent. Nanog levels (Figure 4c) were
elevated in EAsPC-1 cells, whereas it was not elevated in
EPanc-1 cells.
4. Discussion
While we do not wish to generalize from our limited set
of experiments, we would consider evaluating the effect
of overexpression of E-cadherin on the aggressiveness of
differentially behaving pancreatic cancer cell lines. Our
findings show that overexpression of CDH-1 in both
primary and metastatic pancreatic cancer cell lines was
not sufficient to attain complete epithelial characteristics.
Rather, both cell lines remained in interphase in the
progression from a mesenchymal to an epithelial state
where coexpression of both epithelial and mesenchymal
markers was evident, in line with the hybrid EMT/MET
model (Jolly et al., 2015; Smigiel et al., 2018). Transition
states in both directions, either from epithelial-tomesenchymal or mesenchymal-to-epithelial are reversible
processes in nature (Chao et al., 2010). According to this
model, being in the transit hybrid E/M state has a more
aggressive phenotype than retaining either the E or M state
properties that display diminished tumorigenicity (Kroger
et al., 2019).

β-catenin expression is essential for cadherinmediated cell-to-cell adhesion as it is the anchoring
protein connecting the actin cytoskeleton and cadherin
cytoplasmic domain (Heuberger and Birchmeier, 2010).
Seidel et al. demonstrated that when E-cadherin and
N-cadherin are stably expressed in an E-cadherin and
N-cadherin deficient pancreatic cancer cell line MIAPaCa-2, only restoration of E-cadherin expression
promoted an upregulation in β-catenin levels (Rosivatz
et al., 2004). Results from our study confirmed this
positive correlation between E-cadherin and β-catenin
expression in the EPanc-1 cells. However, overexpression
of E-cadherin in EAsPC-1 cells resulted in a slight
downregulation of β-catenin levels. The downregulation
of β-catenin in response to E-cadherin transduction has
been reported by others and it can be explained by the
activation of N-cadherin, which further activates AKT
(Pece et al., 1999; Fang et al., 2007; De Santis et al., 2009;
Zhang et al., 2013). The activation of AKT may not only
account for the downregulation of β-catenin, but also for
the upregulation of Snail (Xu et al., 2015). The expression
of Akt, which is increased in response to the increase in
E-cadherin levels, induced Snail expression in both cell
lines with a significantly higher induction in EAsPC-1
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Figure 3. (a–e) Forced activation of E-cadherin-inhibited EPanc-1 cell migration by gap closure assay. (f–h) The changes in
protein expression levels of pre-Met and Met. (i–j) The invasion and migration capacity of EAsPC-1 cells are analyzed. Mean ±
SD; *P < 0.05, **P < 0.01, and ***P < 0.001, vs. the control group.

cells. This higher increase in Snail levels seen in EAsPC-1
cells can be explained by their higher expression of NF-κB,
which binds directly to the promoter of Snail and controls
its transcriptional upregulation (Pires et al., 2017). Hence,
these findings imply that there is a contrast between the
expression patterns of EMT-related genes in EAsPC-1 cells
and EPanc-1 cells in response to exogenous expression of
E-cadherin.
For example, ZEB-1 upregulation is also seen in
EPanc-1 cells, but not in EAsPC-1 cells, where we detected
rather a decline in ZEB-1 levels in response to the increase
in E-cadherin levels. Moreover, the transduction of
EPanc-1 cells with E-cadherin yields increases in the
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expression not only in ZEB-1, but also in Snail, which
could imply that a hybrid E/M state prevails. As shown
by Kroger et al., hybrid E/M state is a potent enhancer of
tumorigenicity (Kroger et al., 2019). They also claim that
in the absence of Zeb-1, Snail expression triggers the entry
of the cells into the E/M interphase from the E-state, hence
Zeb-1 is critical for Snail-induced transition into M state
(Kroger et al., 2019).
Upon induction of exogenous E-cadherin expression
in EPanc-1 cells that concurrently express Snail and Zeb1, the absence of them inhibits the transition to M state.
We suggest that EPanc-1 cells were positioned into a more
epithelial-like (E-like) state due to the increased Zeb-1 and
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Figure 4. (a) Forced activation of E-cadherin-inhibited EPanc-1 cell colony formation assessed with the colony formation
assay. A representative image and bar graph for colony numbers from 3 independent experiments are shown. (b) Inhibition
in the sphere-forming capacity of EPanc-1 cells while triggering the sphere formation in EAsPC-1 cells. (c–d) Klf4 and Nanog
expressions are shown. Mean ± SD; *P < 0.05, **P < 0.01, and ***P < 0.001, vs. the control group.

enhanced Snail expressions, whereas EAsPC-1 cells stayed
in the E/M hybrid state.
Met, a tyrosine kinase, phosphorylates the cytoplasmic
domain of E-cadherin and promotes its internalization
(Aparicio et al., 2012). The functional impact of Met
downregulation is reflected in our scratch assay results,
where the gap closure was decreased in E-cadherinoverexpressing cells compared to cPanc-1, indicating that
the metastatic potential of EPanc-1 cells is hampered. On
the other hand, slight upregulation of Met in EAsPC-1 cells
suggests that the cells retained their migratory capacity.
High plasticity is an essential property of cancer cells
that disseminate, adapt to the new microenvironment,
and survive within a quiescent state. EMT is involved in
processes related to both dissemination of tumor cells

and their gain of high plasticity. However, when cells
stay in a hybrid state where cells present both E and M
characteristics rather than E or M alone, their degree of
tumorigenicity, as well as plasticity, aggravates (Kroger et al.,
2019). In other words, bearing partial EMT characteristics
is found in association with the highest degree of plasticity
contributing to self-renewal (Weidenfeld and Barkan, 2018;
Zhu et al., 2018). Klf4, which is a tumor suppressor for
pancreatic cancer, is positively correlated with E-cadherin
expression (Zammarchi et al., 2011). Our study confirms
the positive correlation between Klf4 and E-cadherin
expression. Furthermore, we observed a diminished
effect in colony and sphere formation related to increased
KLF4 expressionin EPanc-1 cells (Yan et al., 2016). Since
EAsPC-1 cells do not express Klf4 to a similar extent and
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their Nanog expression is significantly increased, EAsPC-1
cells display enhanced sphere-forming capacity. From
these findings we conclude that the expression level of
Klf4 by itself may not be sufficient to exert a robust effect,
rather, Nanog might play a more potentiating role in sphere
formation in metastatic pancreatic cancer. To validate this
outcome, future studies demonstrating the potentiating
role of Nanog are warranted. In conclusion, cancer stem
cell markers display cumulative effects and their pattern
differs between primary and metastatic pancreatic cancers.
5. Conclusion
Hybrid E/M is a process in which cells acquire mesenchymal
traits while retaining the epithelial state at the same time.
In our study, we aimed to show the differential effects of
exogenously induced E-cadherin expression on primary
pancreatic cancer cells and compared it to those obtained
in a metastatic pancreatic cell line. We clearly observed
that depending on the initialE-cadherin levels, Panc1 cells,which originally had lower levels of E-cadherin
than AsPC-1 cells, gained a differing transition state that
retained their epithelial-like state and lost their sphereforming and migratory capacity. On the other hand,

AsPC-1 cells that already have high levels of E-cadherin
acquired a more hybrid E/M state, as indicated by the
decrease in Zeb1 expression and a slight increase in their
sphere-forming and migratory capacity. To sum up, we
can conclude that E-cadherin is a two-edged sword that
pushes cells into differential transition states where cells
with low levels of E-cadherin have a tendency to stay in
a more epithelial-like state with suppressed tumorigenic
characteristics, and the ones with high levels of E-cadherin
transition into a more hybrid E/M state and become more
tumorigenic.
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